Neural Networks in Neurological and Psychiatric Diseases

Author(s): Felix-Martin Werner.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 4 , 2019

Become EABM
Become Reviewer

[1]
Ahumada-Pascual P, García-Ganan D, Berdei-Montero Y, Velasco A. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP. Curr Pharm Des 2019; 25(4): 376-80.
[2]
Tomasetti C, Montemitro C, Fiengo ALC, et al. Novel pathways in the treatment of major depression: focus on the glutamatergic system. Curr Pharm Des 2019; 25(4): 381-7.
[3]
Werner F-M, Covenas R. Therapeutic effect of novel antidepressant drugs acting at specific receptors of neurotransmitters and neuropeptides. Curr Pharm Des 2019; 25(4): 388-95.
[4]
Werner F-M, Covenas R. Neural networks in generalized epilepsy and novel antiepileptic drugs. Curr Pharm Des 2019; 25(4): 396-400.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 4
Year: 2019
Page: [374 - 375]
Pages: 2
DOI: 10.2174/138161282504190516080951

Article Metrics

PDF: 17
HTML: 5